Quick - what do Simon Property Group Inc. (NYSE:SPG), Dr. Pepper Snapple Group Inc. (NYSE:DPS), and Silicon Image, Inc. (NASDAQ:SIMG) have in common? If you said absolutely nothing, you'd be about 99% right. There's one common thing between SIMG, SPG, and DPS right now, however. What's that? All three stocks are on my personal "buy" list this week.
Every single week, I run a proprietary sort-and-scan of stocks that meet a strict set of fundamental as well as technical criteria. The goal is to find investing ideas that I wouldn't have otherwise found. Otherwise, it's too easy to fall into the trap of buying popular and well-covered (by the media) stocks rather than digging up my own undiscovered value... where the real opportunities are for investors. Truth be told, most of them end up being worthless. Enough of them look attractive enough, however, to explore as trade candidates. As you may have guessed, Silicon Image, Dr. Pepper Snapple Group, and Simon Property Group were the creme of the crop this week.
Best Transportation Stocks To Buy For 2016: Cardiome Pharma Corporation(CRME)
Cardiome Pharma Corp., a life sciences company, engages in developing proprietary drugs to treat or prevent cardiovascular and other diseases. The company offers BRINAVESS, a product approved for marketing in the European Union, Iceland, and Norway for the conversion of recent onset atrial fibrillation to sinus rhythm in adults. It also has clinical programs, which focuses on the treatment of atrial fibrillation, an arrhythmia (or abnormal rhythm) of the upper chambers of the heart. The company has a phase 1 program for GED-aPC, an engineered analog of recombinant human activated Protein C that completed phase I clinical trials for the treatment of infectious disease. In addition, Cardiome Pharma Corp. has pre-clinical projects that focus on cardiac diseases, ion channel conditions, and other indications. It also has a collaboration and license agreement with Merck & Co., Inc. (Merck), for the development and commercialization of vernakalant; and Astellas Pharma US, Inc. t o develop, make, and sell intravenous or injectable formulations of vernakalant in North America. The company was formerly known as Nortran Pharmaceuticals Inc. and changed its name to Cardiome Pharma Corp. in June 2001. Cardiome Pharma Corp. was founded in 1986 and is headquartered in Vancouver, Canada.
Advisors' Opinion:- [By Roberto Pedone]
One under-$10 biopharmaceutical player that's starting to move within range of triggering a big breakout trade is Cardiome Pharma (CRME), which engages in the discovery, development and commercialization of therapies that enhance the health of patients. This stock has been on fire over the last three months, with shares up sharply by 43%.
If you take a look at the chart for Cardiome Pharma, you'll notice that this stock has been trading range bound for the last month or so, with shares moving between $5.85 on the downside and $7.15 on the upside. Shares of CRME have now started to bounce higher off that big support level near $6 a share and it's quickly moving within range of triggering a big breakout trade above some key near-term overhead resistance levels.
Traders should now look for long-biased trades in CRME if it manages to break out above some near-term overhead resistance levels at $6.95 to its 52-week high at $7.15 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 123,602 shares. If that breakout triggers soon, then CRME will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $9 to $10 a share.
Traders can look to buy CRME off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $6 or $5.85 or near its 50-day moving average of $5.63 a share. One can also buy CRME off strength once it starts to take out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By John Udovich]
The biotech sector along with small cap biotech stocks Cardiome Pharma Corp (NASDAQ: CRME), Oncolytics Biotech, Inc (NASDAQ: ONCY), Vital Therapies Inc (NASDAQ: VTL) and TNI BioTech (OTCMKTS: TNIB) have all been producing their share of news this week for investors and traders alike to trade on. Moreover and while some 42 ��ife sciences��companies have gone public raising about $3 billion from investors so far this year, there are a growing number of biotechs pulling the plug on upcoming IPOs who are citing market conditions. With that in mind, here is a look at important news from the biotech sector and small cap biotech stocks this week:
Top 5 Prefered Stocks To Invest In 2015: DineEquity Inc (DIN)
DineEquity, Inc., incorporated on May 07, 1976, owns franchise and operate two restaurant concepts: Applebee's Neighborhood Grill & Bar, (Applebee's), in the bar and grill segment of the casual dining category of the restaurant industry, and International House of Pancakes (IHOP), in the family dining category of the restaurant industry. As of December 31, 2012, the franchise operations segment consisted of 2,011 restaurants operated by Applebee's franchisees in the United States, one United States territory and 15 foreign countries and 1,569 restaurants operated by IHOP franchisees and area licensees in the United States, two United States territories and five foreign countries. As of December 31, 2012, the Company restaurant operations segment consisted of 23 Applebee's Company-operated restaurants, 10 IHOP Company-operated restaurants and two IHOP restaurants reacquired from franchisees and operated by IHOP on a temporary basis until refranchised. Financing operations revenue primarily consists of interest income from the financing of franchise fees and equipment leases, as well as sales of equipment associated with refranchised IHOP restaurants and a portion of franchise fees for restaurants taken back from franchisees not allocated to IHOP intellectual property. In October 2012, it completed the refranchising program and completed the transitioning to a 99% franchised restaurant system.
Applebee's
The Company develops, franchises and operates restaurants in the bar and grill segment of the casual dining category of the restaurant industry under the name Applebee's Neighborhood Grill & Bar. As of December 31, 2012, 68 franchise groups operated 2,011 of these restaurants and 23 restaurants were Company-operated. The restaurants were located in 49 states, one United States territory and 15 countries outside of the United States. During the year ended December 31, 2012, 20 domestic franchise restaurants opened, six domestic franchise restaurants closed. 154 Company-operated! restaurants were franchised. The number of restaurants held by an individual franchisee ranges from one to 438 restaurants. As of December 31, 2012, it is focusing on international franchising primarily in Canada, Mexico, Central and South America, and the Mediterranean/Middle East. As of December 31, 2012, there were 149 international Applebee's franchise restaurants. During 2012, 14 international franchise restaurants opened and 13 international franchise restaurants closed.
IHOP
The Company develops franchises and operates restaurants in the family dining category of the restaurant industry under the names IHOP and International House of Pancakes. As of December 31, 2012 there were a total of 1,581 IHOP restaurants of which 1,404 were subject to franchise agreements, 165 were subject to area license agreements, 10 were Company-operated restaurants and two restaurants were reacquired from franchisees and operated by IHOP on a temporary basis. The Company owns and operates 10 IHOP restaurants in the Cincinnati market area primarily to test new remodel programs, operating procedures, products, technology, cooking platforms and service models. IHOP restaurants are located in all 50 states of the United States, the District of Columbia, Puerto Rico and the United States Virgin Islands and internationally in Canada, the Dominican Republic, Guatemala, Mexico and the United Arab Emirates. As of December 31, 2012, the area licensee for the state of Florida and certain counties in Georgia operated or sub-franchised a total of 152 IHOP restaurants, and the area licensees for the province of British Columbia, Canada operated or sub-franchised a total of 13 IHOP restaurants. As of December 31, 2012, the Company had signed commitments and options from franchisees to build 245 IHOP restaurants over the next 17 years, comprised of 5 restaurants under single-restaurant or non-traditional development agreements, 120 restaurants under multi-restaurant development agreements and 63 restaurants! under in! ternational development agreements. As of December 31, 2012, there were 1,525 domestic IHOP franchise and area license restaurants. During 2012, its franchisees and area licensees opened 40 domestic franchise restaurants and 17 domestic franchise and area license restaurants were closed. As of December 31, 2012, there were 44 international IHOP franchise and area license restaurants. During 2012, its franchisees opened eight international franchise restaurants and no restaurants were closed.
The Company competes with Chili's, T.G.I. Friday's, Ruby Tuesday's, Denny's, Cracker Barrel Old Country Store and Bob Evans Restaurants.
Advisors' Opinion:- [By Peter Graham]
The Q4 2014 earnings report for restaurant stock Bob Evans Farms Inc (NASDAQ: BOBE), a potential peer of Cracker Barrel Old Country Store, Inc. (NASDAQ: CBRL), Denny's Corporation (NASDAQ: DENN) and DineEquity Inc (NYSE: DIN), is scheduled for after the market closes on Tuesday. Aside from the Bob Evans Farms report, it should be said that Cracker Barrel Old Country Store, Inc reported Q3 2014 earnings on May 28th (revenues and profit�rose on�lower expenses); Denny's Corporation reported Q1 2014 earnings on April 28th (they had their strongest quarter of same-store sales at company restaurants in over seven years); and DineEquity Inc reported Q1 2014 on May 1st (earnings rose on stronger sales). However, Bob Evans Farms�recently replaced�three board members with new independent directors after�facing criticism from shareholder Sandell Asset Management Corp.
- [By Ben Levisohn]
Shares of Ruby Tuesday have gained 4.8% to $7.59 this morning, making it the third-best performer in the S&P 1500 and outpacing other restaurant stocks. Jack in the Box (JACK) has dropped 0.8% to $38.76, DineEquity (DIN), which operates Applebee’s and IHOP, has gained 0.1%% to 66.12, Denny’s (DENN) has fallen 0.2% to $6.06 and recent-IPO Potbelly (PBPB) has gained 1.7% to $30.73.
- [By Ben Levisohn]
It is not unheard of for a smaller company in the restaurant space to acquire a larger peer, as evidenced by IHOP’s purchase of the much larger Applebee’s in 2007; the combined entity became DineEquity (DIN), and the deal was financed by a mix of debt (which [DineEquity] still is paying off) and proceeds from the sale of company-owned Applebee’s to franchisees. However, we view BH’s cash flow generation as not sufficient to cover any potential [Cracker Barrel] acquisition, and think Board members will scoff at the idea of selling off highly profitable company-owned sites to franchisees.
Top 5 Prefered Stocks To Invest In 2015: Zoltek Companies Inc (ZOLT)
Zoltek Companies, Inc. is a holding company, which operates through wholly owned subsidiaries, Zoltek Corporation, Zoltek Zrt., Zoltek de Mexico SA de CV, Zoltek de Occidente SA de CV, Engineering Technology Corporation (Entec Composite Machines), Zoltek Properties, Inc., and Zoltek Automotive, LLC. Zoltek Corporation (Zoltek) develops, manufactures and markets carbon fibers and technical fibers in the United States. The Company is an applied technology and advanced materials company. It commercialization of carbon fiber through composites used in a range of commercial products, which it sells under the Panex trade name. In addition to manufacturing carbon fiber, it produces an intermediate product, a stabilized and oxidized acrylic fiber used in flame- and heat-resistant applications, which it sells under the Pyron trade name. During fiscal year ended September 30, 2011 (fiscal 2011), its net sales to Vestas Wind Systems, a wind turbine manufacturer represented % of its net sales. In October 2011, Zoltek purchased a building in St. Peters, Missouri to house its prepreg operations.
Zoltek Zrt. is a Hungarian subsidiary that manufactures and markets carbon fibers and technical fibers and manufactures acrylic fiber precursor raw material used in production of carbon fibers and technical fibers. Zoltek de Mexico SA de CV and Zoltek de Occidente SA de CV are Mexican subsidiaries that manufacture carbon fiber and precursor raw material. Entec Composite Machines manufactures and markets filament winding and pultrusion equipment used in the production composite parts. The Company�� sales markets are in Europe and the United States. The Company has manufacturing plants in Nyergesujfalu, Hungary, Guadalajara, Mexico, Abilene, Texas and St. Charles, Missouri. Its Texas plant houses carbon fiber manufacturing lines and value-added processing capabilities. Its Missouri plant is engaged in the production of technical fibers for aircraft brake and other friction applications and also produces limited! amounts of carbon fibers. In addition, it has facilities in Salt Lake City, Utah where it designs and builds composite manufacturing equipment and produce resin pre-impregnated carbon fibers, called prepregs. It performs certain downstream processing, such as weaving, knitting, blending with other fibers, chopping and milling and preparation of pre-form, pre-cut stacks of fabric. In addition, its Salt Lake City-based Entec Composite Machines subsidiary designs and builds composite manufacturing equipment and markets the equipment along with manufacturing technology and materials. It also provides composite design and engineering for development of applications for carbon fiber reinforced composites.
The Company competes with Hexcel Corporation, Cytec Industries, Toray Group, Toho Tenax, Mitsubishi Chemical and SGL Carbon.
Advisors' Opinion:- [By Maxx Chatsko]
3. Zoltek (NASDAQ: ZOLT )
Zoltek was an interesting investment at the beginning of the year for futurist investors. The company is one of the largest manufacturers of carbon fiber in the world. In fact, its lightweight and high-strength carbon fiber is used almost exclusively in the largest wind turbine blades around the world and played a major role in America's 20-fold improvement in breezy energy capacity since 2000. This material of the future has many other uses and potential uses as well, but Zoltek has never really gained the confidence of the market in any big way: Its market cap was hovering near $300 million at the start of the year. - [By Maxx Chatsko]
Shares of world-leading carbon fiber manufacturer�Zoltek� (NASDAQ: ZOLT ) �have been pushed to new highs after a frantic attempt by Quinpario Partners to acquire a large position in the company. Despite being turned away by management, the fund does make valid points about the company's general lack of progress given its global scope and potential. Investors in this business built around a game-changing material may be worrying whether shares are about to fall back to earth. In the following video, Fool.com contributor Maxx Chatsko gives at least one reason for investors to think that shares can hold their current levels -- or even trek higher.
- [By Lauren Pollock]
Toray Industries Inc.(3402.TO), the global market leader in carbon fiber, agreed to buy smaller rival Zoltek Cos.(ZOLT) in a deal valued at $584 million. The Japanese synthetic-fiber maker offered $16.75 a share, a 9.5% discount to Thurday’s close. Zoltek has struggled amid what it has called a cyclical downturn in the wind energy market. Zoltek shares dropped 10% to $16.58 in light premarket trading.
Top 5 Prefered Stocks To Invest In 2015: Ishares Trust S & P500/Bar (IVW)
iShares S&P 500 Growth Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the Standard & Poor's 500/Citigroup Growth Index (the Index). The Index measures the performance of the large-capitalization growth sector of the United States equity market. It is a subset of the Standard & Poor's 500 Index and consists of those companies exhibiting the strongest growth characteristics in the Standard & Poor's 500 Index, representing approximately 49% of the market capitalization of the Standard & Poor's 500 Index.
The Fund uses a representative sampling strategy in seeking to track the Index. Barclays Global Fund Advisors (BGFA) serves as an advisor to the Fund.
Advisors' Opinion:- [By Jon C. Ogg]
3. U.S. equities record another good year despite enduring a 10% correction – Another 10% correction call, followed by a bull market resumption…. Doll expects that market gains will depend more on earnings growth rather than further multiple expansion. He also would use pullbacks as buying opportunities as most fundamentals continue to improve.
ETF Recommendation: SPDR S&P 500 (NYSEArca: SPY) for broad market, or iShares S&P 500 Growth (NYSEArca: IVW) for a growth focus.4. Cyclical stocks outperform defensive stocks – This puts consumer discretionary, energy, financials, industrials, technology and materials all doing better than consumer staples, healthcare, telecom, and utilities. Doll also prefers a free cash flow yield to dividend yield and dividend growth over dividend yield.
No comments:
Post a Comment